Zoltan Arany. New approach methodologies: Don’t throw the baby out with the bathwater. Cell Metabolism. 2026;38(3):441-442. doi:10.1016/j.cmet.2026.01.009
Michael Morrison, Edison Bicudo. Producing Value or Responding to Valuation? SMEs’ Strategies for Commercialising Induced Pluripotent Stem Cell and Bioprinting Technology. Science & Technology Studies. 2026. doi:10.23987/sts.149468
Rashmi Pandey, Jennifer Lee, Anahita Mojiri, John P. Cooke, Abhishek Jain. Time and architecture: the next two dimensions of microphysiological systems. npj Biomedical Innovations. 2026;3(1):22. doi:10.1038/s44385-026-00077-7
Wenqiang Liu, Paul D. Pang, Catherine A. Wu, Danilo Tagle, Joseph C. Wu. New approach methodologies for drug discovery. Cell. 2026;189(7):1877-1903. doi:10.1016/j.cell.2026.02.012
Ronit Mohapatra, Dowlette-Mary Alam El Din, Hanyu Zhao, Thomas Hartung, Lena Smirnova. Towards learning and memory risk assessment with human brain organoids: barriers and opportunities. Frontiers in Toxicology. 2026;8. doi:10.3389/ftox.2026.1783893
5 perspectives on translating microphysiological systems from concept to application. Nature Communications. 2026;17(1):9148. doi:10.1038/s41467-026-77111-0
Ryan Posey, Alican Özkan, Donald E. Ingber. Human organ-on-a-chip technology as a catalyst for drug discovery. Advanced Drug Delivery Reviews. 2026;236:115920. doi:10.1016/j.addr.2026.115920
Shinya Yamanaka. Two decades of induced pluripotent stem cell research: From discovery to diverse applications. Cell Stem Cell. 2026;33(3):372-381. doi:10.1016/j.stem.2026.02.003